{ }
001122334455554433221100
001122334455554433221100
Symbol MRNA
Name Moderna, Inc.
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Biotechnology
Market NASDAQ Global Select
Country United States
State MA
City Cambridge
Zipcode 2139
Website http://www.modernatx.com

health stocks plunge after trump appoints vaccine skeptic as health secretary

Health stocks have plummeted following Donald Trump's appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary, with Moderna, Pfizer, and GSK experiencing significant losses. The decline has affected US-exposed European healthcare stocks as well, amid growing uncertainty in the vaccine industry. Analysts have downgraded their outlooks on vaccine stocks, reflecting concerns over Kennedy's stance on vaccines and potential policy changes.

analysts deem wall street's reaction to rfk jr appointment as overblown

Wall Street reacted negatively to Robert F. Kennedy Jr.'s appointment as head of the US Health and Human Services Department, causing significant drops in vaccine and healthcare stocks. Analysts believe the market's response may be exaggerated, noting that RFK Jr. has not proposed drastic changes and has stated he does not plan to eliminate vaccines. Concerns stem from his skepticism about the drug approval process and potential influence over key health agencies.

healthcare sector reacts negatively to robert f kennedy jr appointment

Robert F. Kennedy Jr.'s appointment as Health Minister in Donald Trump's administration has triggered a significant decline in pharmaceutical stocks across the US and Europe, with fears of potential drug price caps impacting investor confidence. Major companies like UCB and argenx saw sharp drops, reflecting broader concerns about the future of drug pricing and regulation under Kennedy's leadership. Analysts suggest that while there are constraints on his power, the potential for reduced regulations could lead to increased mergers and acquisitions in the sector.

Vaccine Stocks Plummet After Trump Nominates Kennedy for Health Position

Moderna and Novavax stocks plummeted after President-elect Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services, with shares of Moderna falling over 8% and Novavax nearly 2%. This decline follows Trump's remarks about allowing Kennedy to take a bold approach to healthcare, despite Kennedy's controversial stance against vaccines. Both companies have seen over a 20% drop in stock value in the past week.

Trump appoints Robert F Kennedy Jr to lead health agency amid controversy

President-elect Donald Trump has appointed Robert F. Kennedy Jr., known for his controversial views on vaccines, to lead the Department of Health and Human Services. Kennedy, who previously ran for president as an independent, aims to address chronic diseases and reduce harmful chemicals in food. His appointment has raised concerns among public health advocates about potential negative impacts on health policies and vaccine regulation.

market movements and stock updates following election and health department changes

Traders are closely monitoring market movements following President-elect Trump's nomination of Robert F. Kennedy Jr. for HHS, raising vaccination concerns. Key biotech stocks like Moderna and Pfizer have seen declines, while the SPDR S&P Biotech ETF dropped 3%. In retail, Grocery Outlet and Warby Parker are up significantly, while Boeing's stock has fallen 15% since August amid labor disputes. Upcoming economic data is anticipated to influence market sentiment further.

vaccine maker stocks decline after trump nominates rfk jr for hhs

Shares of vaccine manufacturers plummeted following President-elect Donald Trump's nomination of Robert F. Kennedy Jr., a noted vaccine skeptic, to lead the Department of Health and Human Services. Moderna, Novavax, Pfizer, and BioNTech all experienced significant declines, with Moderna down over 5% and Novavax falling more than 7%. Experts warn that Kennedy's influence could amplify anti-vaccine sentiments, potentially hindering vaccination efforts in the U.S.

pharmaceutical industry scandals and lobbying influence on public health decisions

Pharmaceutical giants like Pfizer and Moderna are profiting immensely from Covid-19 vaccines, with combined profits reaching $65,000 per minute. Despite their financial success, they have largely neglected low-income countries, delivering less than 1% of their vaccine stocks to these regions. The People's Vaccine Alliance highlights the urgent need for equitable vaccine distribution to combat "vaccine apartheid."

Moderna CEO Bancel steps down as chief commercial officer

Moderna CEO Stephane Bancel will step down as the company's chief commercial officer, with president Stephen Hoge taking over sales and medical research responsibilities. Bancel will continue in his role as CEO, following his appointment to lead sales and marketing after the departure of former commercial officer Arpa Garay.

nations agree on biodiversity fund amid challenges for developing countries

Nations have established the "Cali Fund" to ensure companies sharing profits from genetic resources contribute to biodiversity preservation, targeting firms with significant revenues. However, the voluntary nature of contributions raises concerns about the impact on rapid vaccine development and access to genetic data, particularly amid ongoing pandemic negotiations. Critics warn that new regulations could hinder medical research, emphasizing the need for seamless access to digital sequence information for effective health responses.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.